# V14 Adaptive Orchestration Review

## Status

Small Windows alpha passed. General V14 release review remains open.

## Review Outcome

`PASS` for the exact small Release Board dogfood after three independent review attempts.

## Spec Alignment

AC1-AC9 are implemented. The small portion of AC10 is complete. Medium and high-risk dogfoods,
exact-candidate qualification, hosted Windows CI, and final release review remain.

## Architecture Alignment

The implementation preserves ADR 0007: specialist demand is provider-neutral, host supply owns
model and effort identifiers, routing hard-gates quality and authority before cost, core projects
commands without claiming host effects, V12 owns immutable settlement, and one integration owner
assembles the result.

## Verification Evidence

- `evidence/dogfood-small/verification.md`
- `evidence/dogfood-small/integration-record.json`
- `evidence/dogfood-small/independent-review.md`
- `evidence/dogfood-small/release-alpha-attestation.json`
- `evidence/dogfood-small/browser/qa-result.json`
- Release Board: 14 reviewed tests, then 15 tests including the closeout attestation check
- V14 focused routing and adaptive tests: 26 passed
- Previously committed core tests: 513 passed
- Isolated lifecycle tests: 2 passed

## Findings

| Severity | Finding | Resolution |
| --- | --- | --- |
| P1 | RunView proved fan-in but not post-integration completion | Added a separate integration record that binds both exact RunView forms and is revalidated by tests |
| P2 | Persistence failure could be masked by success feedback | Consolidated action and persistence outcomes into one tested announcement |
| P2 | Add shortcut ignored reduced-motion preference | Added a tested reduced-motion policy and verified the active reduced-motion browser branch |
| P2 | Browser evidence was not source-bound | Added exact app and screenshot hashes plus a regression test that recomputes every binding |
| P2 | Early integration evidence used an ambiguous RunView hash field | Bound JSON and Markdown paths and hashes separately |

Final independent successor review: no findings; `PASS`.

## Residual Risks

- Only the small-goal Windows path is proven.
- Runtime capability calibration remains host- and owner-supplied.
- Activation is currently instruction-driven rather than a one-command orchestration CLI.
- General release still requires medium and high-risk recovery evidence plus hosted qualification.

## Memory And Docs

The alpha activation path is in `AGENTS.md` and `README.md`. The milestone, active context, history
ledger, and retrieval index record the bounded small-alpha result without claiming general release.
